anfoe 6000iu injection - Recombinant Human Erythropoietin Alfa (6000IU) medicine

Anfoe 6000IU Injection: Comprehensive Medicine Guide

No reviews yet
🏭 La Renon Healthcare Pvt Ltd 📦 Varies by brand 💊 Allopathy 📅 Updated: Sep 22, 2026
📋 Prescription Required 💊 Generic Available
Medically Reviewed
11 min read
Evidence: Well-established for approved indications.
Reviewed by
SaathiMed Expert Panel | Sep 22, 2026

When to Call Your Doctor IMMEDIATELY

  • Chest pain or pressure
  • Shortness of breath or difficulty breathing
  • Swelling, pain, or redness in one leg
  • Sudden severe headache, confusion, or seizures
  • Signs of severe allergic reaction (rash, itching, swelling of face/throat)
  • Unusual fatigue or paleness (may indicate pure red cell aplasia)
  • Decreased urine output

If experiencing severe symptoms, call emergency services immediately.

What is anfoe 6000iu injection used for?

This medicine is a recombinant human erythropoietin alfa injection used to treat anemia in chronic kidney disease, chemotherapy, and HIV patients. It stimulates red blood cell production and is given intravenously by a healthcare professional.

  • Generic Name: Recombinant Human Erythropoietin Alfa
  • Manufacturer: La Renon Healthcare Pvt Ltd
  • Form: Allopathy
  • Pregnancy Category: Consult doctor
  • Prescription Required: Yes

🇮🇳 anfoe 6000iu injection के बारे में (Hindi Summary)

उपयोग: यह दवा रक्ताल्पता (एनीमिया) के इलाज के लिए दी जाती है, खासकर क्रोनिक किडनी रोग, कीमोथेरेपी और एचआईवी संक्रमण वाले मरीजों में। यह शरीर में लाल रक्त कोशिकाओं का उत्पादन बढ़ाती है। यह इंजेक्शन के रूप में नस के माध्यम से दी जाती है और इसे डॉक्टर या नर्स द्वारा ही लगाया जाता है।

साइड इफेक्ट्स: आम दुष्प्रभावों में उच्च रक्तचाप, सिरदर्द, जोड़ों में दर्द, मतली और इंजेक्शन की जगह पर प्रतिक्रिया शामिल हैं। गंभीर दुष्प्रभावों में रक्त के थक्के बनना, दौरे पड़ना और गंभीर एलर्जी शामिल हो सकते हैं। अगर सीने में दर्द, सांस लेने में कठिनाई या पैर में सूजन हो तो तुरंत डॉक्टर से संपर्क करें।

सुरक्षा सलाह: यह दवा केवल डॉक्टर की देखरेख में ही दी जानी चाहिए। इसे स्वयं न लगाएं। नियमित रूप से हीमोग्लोबिन और रक्तचाप की जांच कराते रहें। कोई भी नया लक्षण जैसे सीने में दर्द, सांस लेने में तकलीफ या पैर में सूजन हो तो तुरंत डॉक्टर को बताएं। गर्भवती या स्तनपान कराने वाली महिलाएं डॉक्टर को सूचित करें।

💡 Did You Know? India is the largest provider of generic medicines globally, supplying over 50% of global vaccine demand.

💊 anfoe 6000iu injection Uses & Benefits

[{"condition":"Anemia of chronic kidney disease","description":"This medicine stimulates red blood cell production in patients with chronic kidney disease who are not on dialysis or are on dialysis.","evidence":"Well-established"},{"condition":"Chemotherapy-induced anemia","description":"Used to treat anemia in patients with non-myeloid malignancies receiving myelosuppressive chemotherapy.","evidence":"Well-established"},{"condition":"Anemia in HIV-infected patients on zidovudine","description":"Helps manage anemia associated with zidovudine therapy in HIV-positive patients.","evidence":"Well-established"},{"condition":"Anemia in patients undergoing surgery","description":"May be used to reduce the need for allogeneic blood transfusions in patients undergoing elective surgery.","evidence":"Established"}]

Off-label uses: [{"condition":"Anemia of prematurity","description":"Sometimes used off-label in premature infants to reduce transfusion needs.","evidence":"Limited"},{"condition":"Myelodysplastic syndromes","description":"May be used off-label to treat anemia in some patients with myelodysplastic syndromes.","evidence":"Limited"}]

Primary treatment for: Anemia

Also treats: Chronic kidney disease, Cancer, HIV infection

📋 Drug Information

Generic Name(s)Recombinant Human Erythropoietin Alfa
Brand NameAnfoe 10000IU Injection
ManufacturerLa Renon Healthcare Pvt Ltd
Packaging / FormVaries by brand (Allopathy)
Therapeutic ClassBLOOD RELATED
Action ClassErythropoiesis-stimulating agent (ESA)
Route of AdministrationIntravenous
StorageStore refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. Do not shake. Keep in the original carton to protect from light.
Shelf Life24 months from the date of manufacture.
WHO GuidelineNot established from the available information.
ICMR GuidelineNot established from the available information.

👨‍⚕️ Doctor's Practical Tips

Evidence-based practical advice from experienced clinicians

1
Monitor blood pressure closely before and during therapy; hypertension is common.
2
Ensure adequate iron stores before initiating treatment; iron deficiency reduces efficacy.
3
Target hemoglobin levels should be individualized; avoid exceeding 11 g/dL in CKD and 12 g/dL in cancer.
4
Evaluate for pure red cell aplasia if there is a sudden loss of response or need for increased transfusions.
5
Use with caution in patients with a history of seizures or thromboembolic events.
6
Educate patients on recognizing signs of thromboembolism and when to seek immediate care.

🔍 Is This Medicine Right for Your Symptom?

Educational reference. Always consult a doctor for diagnosis.

Fatigue and weakness
This medicine is used to treat anemia, which causes fatigue.
Likely Use
Shortness of breath
Anemia can cause shortness of breath; this medicine may help.
Likely Use
Fever
This medicine is not a primary fever reducer.
Not Primary

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

AbsorptionThis medicine is administered intravenously, so absorption is not applicable. It is directly introduced into the bloodstream.
DistributionThe volume of distribution is approximately 0.05 to 0.1 L/kg. It is primarily distributed in the plasma and does not extensively penetrate tissues.
Protein BindingNot established from the available information.
MetabolismThe metabolism of recombinant human erythropoietin alfa is not fully characterized. It is believed to be metabolized via general protein catabolism in the body.
Half-LifeThe elimination half-life after intravenous administration is approximately 4 to 13 hours in patients with chronic kidney disease. It may be longer in patients with renal impairment.
ExcretionThe exact route of excretion is not well established. It is thought to be eliminated via the kidneys and through metabolism.
BioavailabilityBioavailability is 100% when administered intravenously.
Onset of ActionAn increase in reticulocyte count can be observed within 3 to 7 days. A significant rise in hemoglobin may take 2 to 6 weeks.
Peak Plasma TimePeak plasma concentration occurs at the end of intravenous infusion.
Duration of ActionThe effect on red blood cell production lasts for several days to weeks, depending on the dose and individual response.

How It Works

Recombinant human erythropoietin alfa binds to erythropoietin receptors on the surface of erythroid progenitor cells in the bone marrow. This binding activates intracellular signaling pathways, primarily the JAK2/STAT5 pathway, which promotes cell survival, proliferation, and differentiation into mature red blood cells. It also stimulates the release of reticulocytes from the bone marrow into the bloodstream, thereby increasing red blood cell count and hemoglobin levels.

Mechanism Steps

1
Binding to erythropoietin receptor: This medicine binds to erythropoietin receptors on erythroid progenitor cells in the bone marrow.
2
Activation of JAK2/STAT5 pathway: The binding triggers phosphorylation of JAK2 kinase, which then activates STAT5 transcription factors.
3
Promotion of cell survival and proliferation: Activated STAT5 translocates to the nucleus and induces expression of genes that prevent apoptosis and stimulate cell division.
4
Differentiation into red blood cells: Erythroid progenitor cells differentiate into proerythroblasts and eventually mature red blood cells.
5
Increased red blood cell count: Mature red blood cells are released into the circulation, raising hemoglobin and hematocrit levels.

💡 How to Take anfoe 6000iu injection

Strength: 6000 IU injection

1This medicine is administered by a healthcare professional.
2It is given as an intravenous injection or infusion.
3Do not self-administer.
4Follow your healthcare provider's instructions for monitoring and follow-up.

Dosage Information

Adult DosageThe dose of this medicine must be individualized by a qualified clinician based on the indication, patient's age, weight, renal and hepatic function, and response to therapy. For anemia of chronic kidney disease, the typical starting dose is 50 to 100 IU/kg three times per week intravenously. For chemotherapy-induced anemia, the typical starting dose is 150 IU/kg three times per week or 40,000 IU once weekly. Dose adjustments are made based on hemoglobin levels. Do not self-administer.
Pediatric DosagePediatric dosing is not established from available information. Consult a pediatrician.
Elderly DosageElderly patients may be more sensitive to the effects of this medicine. Dose selection should be cautious, reflecting the greater frequency of decreased renal, hepatic, or cardiac function.
Renal ImpairmentIn patients with chronic kidney disease, the dose should be individualized based on hemoglobin levels and clinical response. Monitor closely for hypertension and cardiovascular events.
Hepatic ImpairmentNo specific dosage adjustments are provided for hepatic impairment. Use with caution and monitor closely.
Maximum Daily DoseNot established from the available information.

Dosage Timeline

🌅 Morning ❌ ☀️ Afternoon ❌ 🌆 Evening ❌ 🌙 Night ❌

⏰ What to Do If You Miss a Dose

📌 If you miss a scheduled dose
→ Contact your healthcare provider as soon as possible.
💡 Do not attempt to self-administer a double dose.

⚠️ Side Effects of anfoe 6000iu injection

✅ Common Side Effects

Hypertension (Common (10-20%))
Monitor blood pressure regularly. If elevated, consult your doctor for adjustment of antihypertensive therapy.
Headache (Common (5-15%))
Usually resolves on its own. If persistent or severe, consult your doctor.
Joint pain (Common (5-10%))
Over-the-counter pain relievers may help. Consult your doctor if it interferes with daily activities.
Nausea (Common (5-10%))
Take small, frequent meals. If nausea persists, consult your doctor.
Injection site reaction (Common (5-10%))
Apply a cold compress. Report any signs of infection to your doctor.

🚨 Serious Side Effects

Thromboembolic events (e.g., deep vein thrombosis, stroke, myocardial infarction) (Uncommon (1-5%))
Seek immediate medical attention if you experience chest pain, shortness of breath, swelling in one leg, or sudden severe headache.
Pure red cell aplasia (Rare (<0.1%))
Report any sudden decrease in hemoglobin or need for increased transfusions to your doctor immediately.
Seizures (Rare (<0.1%))
Seek emergency medical help if you experience convulsions or loss of consciousness.
Severe allergic reactions (Rare (<0.1%))
Get emergency help if you notice rash, itching, swelling of face or throat, or difficulty breathing.

⚠️ Rare Side Effects

Hypertensive encephalopathy
Seek immediate medical attention if you experience severe headache, confusion, or seizures.
Hyperkalemia
Report muscle weakness or irregular heartbeat to your doctor.

Consult your doctor if you experience any unusual symptoms.

🔬 Drug Interactions

Drug Severity Effect
Antihypertensives Major
Warfarin Major
Cyclosporine Moderate
Iron supplements Moderate
Androgens Minor

🚨 Major Interactions

  • Antihypertensive drugs
  • Warfarin

⚡ Moderate Interactions

  • Cyclosporine
  • Iron supplements

🍷 Alcohol Interaction

Alcohol may increase the risk of hypertension and may worsen anemia. It is advisable to avoid or limit alcohol consumption while receiving this medicine.

🔎 Check Your Other Medicines

Educational tool. Always confirm with your doctor or pharmacist.

🛡️ Safety & Warnings

🚫 Contraindications

["Uncontrolled hypertension","Known hypersensitivity to recombinant human erythropoietin alfa or any excipient","Pure red cell aplasia","Use in patients with chronic kidney disease not on dialysis with hemoglobin >10 g/dL","Use in cancer patients with hemoglobin >12 g/dL"]

⚠️ Warnings & Precautions

["This medicine may increase the risk of serious cardiovascular events, including death, when administered to patients with chronic kidney disease or cancer.","Blood pressure should be monitored closely. Hypertensive encephalopathy and seizures have occurred.","Patients with a history of seizures should be monitored closely.","This medicine may cause pure red cell aplasia; if suspected, discontinue and evaluate.","Ensure adequate iron stores before and during therapy.","Do not use in patients with uncontrolled hypertension.","Use with caution in patients with a history of thrombosis."]

🤱 Lactation Safety

It is not known whether this medicine is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when administered to a nursing woman.

💊 Overdose Management

Overdose may cause polycythemia, which can lead to increased blood viscosity and thromboembolic events. Treatment is symptomatic and supportive. In case of overdose, discontinue the medicine and monitor hemoglobin and hematocrit. Phlebotomy may be considered if necessary.

⏰ Missed Dose

If you miss a dose, contact your healthcare provider for instructions. Do not double the dose to catch up.

Additional Safety Advice

General Safety

This medicine must be administered by a healthcare professional. Do not self-administer. Your doctor will monitor your hemoglobin levels regularly to ensure they remain within the target range. Report any new or worsening symptoms such as chest pain, difficulty breathing, or swelling in the legs immediately. Maintain regular follow-up visits for blood pressure and iron level checks. Do not increase or decrease the dose without medical advice. Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding. Avoid driving or operating heavy machinery if you feel dizzy or unwell after the injection.

👴 Special Considerations for Elderly

💡 For Patients Above 65

Elderly patients may be more sensitive to the effects of this medicine, particularly regarding blood pressure and cardiovascular risks. Dose selection should be cautious, and monitoring should be more frequent.

🤰 Pregnancy Planning (TTC)

If you are planning pregnancy, consult your doctor before starting or continuing this medicine. It is Pregnancy Category C, and the potential risks and benefits should be discussed.

🏥 Post-Surgery Considerations

This medicine may be used to reduce the need for blood transfusions after surgery. Follow your doctor's instructions for dosing and monitoring.

🦷 Dental Procedures

Inform your dentist that you are receiving this medicine. No specific precautions are required, but maintain good oral hygiene.

💚 Lifestyle Tips for Better Results

🏃
Maintain a healthy diet rich in iron, vitamin B12, and folate to support red blood cell production.
🥗
Monitor your blood pressure regularly at home and keep a record.
😴
Stay physically active as tolerated to improve overall health.
💧
Avoid smoking and limit alcohol consumption.
🧘
Attend all scheduled follow-up appointments for blood tests and assessments.

🏋️ Exercise Considerations

Engage in light to moderate exercise as tolerated. Avoid strenuous activities if you feel dizzy or short of breath. Consult your doctor before starting any new exercise program.

🥗 Diet Recommendations

Include iron-rich foods such as lean meat, beans, and leafy greens.
Ensure adequate vitamin C intake to enhance iron absorption.
Avoid excessive intake of caffeine and calcium supplements with iron-rich meals as they can inhibit iron absorption.

💼 Impact on Daily Work & Life

This medicine may cause dizziness or fatigue in some patients. Avoid driving or operating heavy machinery until you know how it affects you. Most patients can continue their daily activities, but listen to your body and rest when needed.

🛑 When to Stop This Medicine

Do not stop this medicine without consulting your doctor. If you experience serious side effects or if your hemoglobin levels exceed the target range, your doctor may adjust or discontinue therapy.

📅 Long-Term Use Effects

Long-term use of this medicine may increase the risk of cardiovascular events, including stroke, heart attack, and heart failure, especially if hemoglobin levels are raised above the recommended target. Regular monitoring of hemoglobin, blood pressure, and iron stores is essential. Patients with chronic kidney disease may require ongoing therapy. Periodic evaluation of the risk-benefit ratio is necessary.

🌿 Non-Medicine Approaches

These can complement medicine but do not replace prescribed treatment.

Iron supplementation

Oral or intravenous iron can help correct iron deficiency anemia.

Evidence: Well-established
Blood transfusion

May be used for severe anemia or when rapid correction is needed.

Evidence: Well-established

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

No specific interactions with vaccines are known. However, consult your doctor before receiving any vaccine while on this medicine.

📦 Storage Guide

✅ DO

Store refrigerated at 2°C to 8°C

❌ DON'T

Do not freeze

✅ DO

Keep in original carton to protect from light

❌ DON'T

Do not shake

✅ DO

Keep out of reach of children

❌ DON'T

Do not use if expired

✈️ Traveling with This Medicine

Carry this medicine in its original packaging with a copy of your prescription. Store it in a refrigerator or a cool bag with ice packs during travel. Inform airport security about the medication and any needles if you are carrying them. Check with your destination&#039;s customs regulations regarding injectable medications. Plan for time zone adjustments if your dosing schedule is affected.

💰 Cost Analysis & Savings

👥 Real Patient Stories

Educational, anonymized scenarios. Individual results may vary.

👤 A 58-year-old man with chronic kidney disease on dialysis
He had severe anemia causing fatigue and breathlessness. His doctor started him on this medicine intravenously three times a week. After 6 weeks, his hemoglobin improved from 7.5 to 10.5 g/dL, and he felt more energetic. He monitored his blood pressure regularly and reported no major side effects.
💡 Lesson: Regular monitoring and adherence to the prescribed schedule are key to improving anemia and quality of life.
👤 A 45-year-old woman undergoing chemotherapy for breast cancer
She developed anemia during chemotherapy, leading to extreme tiredness. Her oncologist prescribed this medicine weekly. After 4 weeks, her hemoglobin stabilized, and she required fewer blood transfusions. She experienced mild headache and joint pain, which were managed with simple pain relievers.
💡 Lesson: This medicine can effectively manage chemotherapy-induced anemia, but patients should report any new symptoms to their doctor.

💬 Questions Patients Often Ask

Q: How long does it take to work?

A: An increase in reticulocyte count can be seen within 3 to 7 days, but a significant rise in hemoglobin may take 2 to 6 weeks.

Q: How is this medicine administered?

A: It is given as an intravenous injection by a healthcare professional.

Q: What are the common side effects?

A: Common side effects include hypertension, headache, joint pain, nausea, and injection site reactions.

Q: Is it safe during pregnancy?

A: It is Pregnancy Category C. Use only if the potential benefit justifies the potential risk to the fetus. Consult your doctor.

Q: Can I self-administer this injection?

A: No, this medicine must be administered by a healthcare professional.

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

  • Can I take this medicine long-term?
  • Will it affect my kidney function?
  • Can I drive after taking this medicine?
  • Does it interact with my blood pressure medicine?
  • What if I miss a dose?
  • Can I drink alcohol while taking this?

🔄 Substitutes for anfoe 6000iu injection

View All

Alternative brands with exact same active ingredient:

Medical Note: Always consult your doctor before switching medications.

🛑 Myths vs. Facts

  • Myth: This medicine can be self-administered at home.
    Fact: This medicine must be administered by a healthcare professional.
  • Myth: This medicine is a blood transfusion substitute.
    Fact: This medicine stimulates red blood cell production but is not a substitute for blood transfusion in emergencies.

🔄 Alternative Options

Generic Alternatives

  • Recombinant human erythropoietin alfa

Brand Alternatives

  • Eprex
  • Epogen
  • Procrit
  • NeoRecormon

📊 Comparison with Similar Medicines

[{"medicine":"Recombinant human erythropoietin alfa","difference":"Short-acting ESA, requires frequent dosing."},{"medicine":"Darbepoetin alfa","difference":"Long-acting ESA, less frequent dosing."},{"medicine":"Methoxy polyethylene glycol-epoetin beta","difference":"Long-acting ESA, monthly dosing."}]

😊 Was this information helpful?

Browse Medicines A-Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory